Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new Locations section appears with the Texas site (Houston, MD Anderson Cancer Center). The page revision is updated to v3.3.3, and the old Texas Locations label along with the HHS Vulnerability Disclosure footer link were removed.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.3.2 has been added and v3.2.0 removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedResults for the trial have been posted and the results section updated, including primary and secondary outcomes. The update is reflected in the Study Record Dates with Results First Posted on 2025-02-19.SummaryDifference0.4%

- Check90 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check97 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.